Table 2.
Clinical Assessments—All Treatment Sites Combined
| Score immediately post‐treatment | ||||
|---|---|---|---|---|
| Assessment parameter a | 0 Absent | 1 Minor | 2 Moderate | 3 Severe |
| Bruising | 64 (62%) | 31 (30%) | 7 (7%) | 1 (1%) |
| Erythema/purpura | 0 (0%) | 54 (52%) | 46 (45%) | 3 (3%) |
| Edema | 31 (30%) | 46 (45%) | 25 (24%) | 1 (1%) |
| Numbness | 14 (14%) | 30 (29%) | 47 (46%) | 12 (12%) |
| Tingling | 56 (54%) | 32 (31%) | 12 (12%) | 3 (3%) |
a
The abdominal site and each flank site were evaluated separately. In this Table all such evaluations are combined. One subject was treated on the abdomen only—flank treatments were not possible due to inadequate tissue draw into the applicator.